Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Skin Neoplasms × Cyclosporine × Clear all

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia 18 Leukemia, Myeloid, Acute 16 Precursor Cell Lymphoblastic Leukemia-Lymphoma 15 Leukemia, Lymphocytic, Chronic, B-Cell 14 Lymphoma 13 Myelodysplastic Syndromes 12 Multiple Myeloma 12 Lymphoma, Non-Hodgkin 12 Lymphoma, Large B-Cell, Diffuse 12 Lymphoma, Mantle-Cell 11 Hodgkin Disease 11 Primary Myelofibrosis 10 Lymphoma, Follicular 10 Burkitt Lymphoma 10 Lymphoma, Large-Cell, Immunoblastic 9 Lymphoma, B-Cell, Marginal Zone 9 Leukemia, Myeloid, Accelerated Phase 9 Congenital Abnormalities 9 Neoplasms, Plasma Cell 8 Leukemia, Myeloid, Chronic-Phase 8 Graft vs Host Disease 8 Recurrence 7 Myeloproliferative Disorders 7 Myelodysplastic-Myeloproliferative Diseases 7 Leukemia, Myelomonocytic, Juvenile 7 Leukemia, Myelomonocytic, Chronic 7 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 7 Dendritic Cell Sarcoma, Interdigitating 7 Anemia, Refractory, with Excess of Blasts 7 Blast Crisis 6

Interventions

Cyclophosphamide 11 fludarabine 8 aldesleukin 8 fludarabine phosphate 6 pembrolizumab 5 Nivolumab 4 Ipilimumab 4 Interleukin-2 4 dabrafenib 2 Vemurafenib 2 Biopsy 2 Aminolevulinic Acid 2 varlilumab 1 trametinib 1 tilsotolimod 1 spartalizumab 1 sotigalimab 1 sonidegib 1 smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic 1 glembatumumab vedotin 1 eprenetapopt 1 encorafenib 1 cemiplimab 1 cabozantinib 1 binimetinib 1 bempegaldesleukin 1 abobotulinumtoxinA 1 X-Rays 1 Tranexamic Acid 1 Tacrolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00866684 2025-03-14

PROSKIN

Charite University, Berlin, Germany

Phase 4 Terminated

44 enrolled 7 charts

Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡